The Hemophilia Federation of America and the National Hemophilia Foundation are pleased to share a brief update with the community concerning a recent meeting with the FDA as well as a number of additional resources that the FDA provided after the call. 
HFA and NHF will continue to update the bleeding disorders community as any further information develops.
Please note that NHF and HFA do not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific products, treatments, or opinions. If you have any questions or concerns about your medical treatment, including your possible exposure to recalled product, please consult your physician.
